NCT07445555 Gingival Recessions in Orthodontically Treated and Untreated Adult Patients
| NCT ID | NCT07445555 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Gingival Recession |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-11-15 |
| Primary Completion | 2026-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-11-15 with a primary completion date of 2026-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To identify the predisposing parameters for gingival recessions in adult patients seeking orthodontic treatment. The ultimate aim is to provide a clinical guideline to estimate the risk of developing post-orthodontic gingival recessions.
Eligibility Criteria
Inclusion Criteria: * Patients with or without previous history of orthodontic treatment with and without gingival recessions * ≥ 18 years old * American Society of Anesthesiologists Classification I or II Exclusion criteria: * Patients with history of periodontal disease * taking the following medication: anticoagulants, phenytoin, cyclosporine, nifedipine or calcium channel blockers * Patients with prior history of radio or chemotherapy * Pregnant or breastfeeding patients * Patients with agenesis of one or more lower incisors Exclusion Criteria: Patients with history of periodontal disease Patients taking the following medication: anticoagulants, phenytoin, cyclosporine, nifedipine or calcium channel blockers Patients with prior history of radio or chemotherapy Pregnant or breastfeeding patients Patients with agenesis of one or more lower incisors
Contact & Investigator
Ana Castro
PRINCIPAL INVESTIGATOR
Universitaire Ziekenhuizen KU Leuven
Frequently Asked Questions
Who can join the NCT07445555 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gingival Recession. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07445555 currently recruiting?
Yes, NCT07445555 is actively recruiting participants. Contact the research team at ana.castro@uzleuven.be for enrollment information.
Where is the NCT07445555 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT07445555 clinical trial?
NCT07445555 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Ana Castro at Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 50 participants.